Like
Be the first to like this
Our next article is live on the Bioentrepreneur website. Titled In vogue with venture, it was written by Gary Patou, managing director at MPM Capital. (You can find his bio page here.)
His piece details what MPM finds attractive today, and explains why. He also provides some insight into companies MPM has invested in recently, and discusses the reasoning for turning down an opportunity with a type 2 diabetes drug. You can read it here; for the PDF, go here.
We’ve also highlighted an article from the Bioentrepreneur archives. It investigates non-dilutive funding from foundations. Click on the link to read it.
Brady Huggett
Follow the Topic
Biotechnology
Life Sciences > Biological Sciences > Biotechnology
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in